MedTrace Logo

Proteomic Analysis Reveals Innate Immune Activity In Intestinal Transplant Dysfunction

NCT01140152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2026-04-14

No results posted yet for this study

Summary

Many patients with intestinal failure require intestinal transplantation for survival. Currently, the gold standard for diagnosing acute cellular rejection (ACR) is histological examination of endoscopic biopsies, which are taken invasively and lack sensitivity. A non-invasive method of monitoring for ACR is needed.

Conditions

  • Intestinal Transplant
  • Cellular Rejection

Sponsors & Collaborators

Principal Investigators

  • Anjuli R Kumar, M.D. · University of California, Los Angeles

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01140152 on ClinicalTrials.gov